News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
8,346 Results
Type
Article (729)
Company Profile (1)
Press Release (7615)
Multimedia
Podcasts (5)
Webinars (1)
Section
Business (2765)
Career Advice (16)
Deals (377)
Drug Delivery (5)
Drug Development (1277)
Employer Resources (3)
FDA (255)
Job Trends (159)
News (4603)
Policy (354)
Tag
Academia (31)
Accelerated approval (4)
Alliances (959)
ALS (1)
Alzheimer's disease (12)
Antibody-drug conjugate (ADC) (6)
Approvals (262)
Artificial intelligence (11)
Autoimmune disease (4)
Automation (1)
Bankruptcy (10)
Best Places to Work (94)
BIOSECURE Act (1)
Biosimilars (20)
Biotechnology (1)
Bladder cancer (1)
Breast cancer (8)
Cancer (77)
Cardiovascular disease (7)
Career advice (15)
Cell therapy (6)
Clinical research (1089)
Collaboration (71)
Compensation (4)
COVID-19 (13)
C-suite (24)
Cystic fibrosis (6)
Data (59)
Diabetes (8)
Diagnostics (43)
Digital health (4)
Drug discovery (3)
Drug pricing (21)
Earnings (777)
Editorial (1)
Employer branding (1)
Employer resources (2)
Events (825)
Executive appointments (22)
FDA (290)
Funding (28)
Generative AI (3)
Gene therapy (7)
GLP-1 (70)
Government (56)
Guidances (5)
Healthcare (138)
IgA nephropathy (1)
Immunology and inflammation (10)
Immuno-oncology (1)
Indications (2)
Infectious disease (17)
Inflammatory bowel disease (5)
Inflation Reduction Act (1)
Influenza (2)
Intellectual property (2)
Interviews (4)
IPO (178)
IRA (10)
Job creations (69)
Job search strategy (15)
Labor market (2)
Layoffs (13)
Legal (83)
Lung cancer (32)
Machine learning (1)
Management (1)
Manufacturing (8)
MASH (16)
Medical device (72)
Medtech (73)
Mergers & acquisitions (195)
Metabolic disorders (48)
mRNA (4)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (32)
NextGen: Class of 2026 (70)
Non-profit (36)
Now hiring (1)
Obesity (29)
Opinion (7)
Ovarian cancer (1)
Parkinson's disease (3)
Patents (4)
People (963)
Pharmacy benefit managers (3)
Phase 1 (258)
Phase 2 (448)
Phase 3 (409)
Pipeline (95)
Policy (15)
Postmarket research (115)
Preclinical (83)
Rare diseases (13)
Real estate (72)
Recruiting (1)
Regulatory (277)
Reports (1)
Research institute (29)
Resumes & cover letters (1)
RNA editing (1)
Schizophrenia (10)
Series A (9)
Series B (6)
Special edition (1)
Startups (61)
Supply chain (1)
The Weekly (5)
Vaccines (10)
Venture capital (3)
Weight loss (25)
Date
Today (2)
Last 7 days (10)
Last 30 days (30)
Last 365 days (324)
2026 (106)
2025 (318)
2024 (413)
2023 (371)
2022 (667)
2021 (669)
2020 (584)
2019 (520)
2018 (377)
2017 (536)
2016 (489)
2015 (451)
2014 (374)
2013 (333)
2012 (325)
2011 (309)
2010 (336)
Location
Africa (19)
Alabama (1)
Arizona (2)
Asia (264)
Australia (66)
California (234)
Canada (7)
China (7)
Colorado (1)
Connecticut (26)
Europe (2269)
Florida (2)
Georgia (8)
Illinois (9)
India (2)
Indiana (8)
Japan (7)
Kansas (1)
Maryland (1)
Massachusetts (49)
Michigan (2)
Missouri (1)
Nevada (1)
New Hampshire (1)
New Jersey (10)
New York (14)
North Carolina (6)
Northern California (60)
Oklahoma (1)
Oregon (1)
Pennsylvania (6)
South America (21)
Southern California (120)
Tennessee (1)
Texas (5)
United States (392)
Utah (1)
Virginia (1)
Washington D.C. (2)
Washington State (16)
8,346 Results for "boehringer ingelheim fremont".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows
April 13, 2026
·
4 min read
Press Releases
Ecuador Free of Rabies project accelerates progress toward eliminating dog-mediated rabies supported by Boehringer Ingelheim’s Stop Rabies program
April 9, 2026
·
4 min read
Press Releases
Click Therapeutics and Boehringer Ingelheim Announce Series D Investment and Funding to Advance Commercialization of CT-155
April 9, 2026
·
8 min read
Deals
Boehringer Seeks To Rebalance Immunity With Sitryx Collab Potentially Worth $500M+
While Boehringer Ingelheim hasn’t yet revealed what diseases it will go after, Sitryx’s oral drug candidate could potentially be disease-modifying for a variety of autoimmune and inflammatory conditions.
February 26, 2026
·
1 min read
·
Tristan Manalac
Press Releases
CDR-Life Announces First Milestone Achievement in Boehringer Ingelheim Autoimmune Partnership
March 23, 2026
·
2 min read
Collaboration
Boehringer Ingelheim Bets up to Nearly $1B in ADC Play With AimedBio Deal
2025 has been a busy year for Boehringer Ingelheim, which has so far inked at least five hefty partnerships—including its latest one with South Korea’s AimedBio for an antibody-drug conjugate therapy for cancer.
October 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
OpenProtein.AI Expands Strategic Partnership with Boehringer Ingelheim to Advance AI-Driven Antibody Discovery
March 31, 2026
·
3 min read
MASH
Boehringer Ingelheim Axes MASH Pact With OSE After Disappointing Mid-Stage Data
OSE Immunotherapeutics has kicked off a strategic realignment initiative that involves deprioritizing the AbbVie-partnered OSE-230 and focusing its resources on the late-stage development of its ulcerative colitis candidate lusvertikimab.
March 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement
April 8, 2026
·
6 min read
Press Releases
Boehringer Ingelheim delivers on late-stage pipeline with two key launches, grows sales by 7.3%* in a successful 2025
March 25, 2026
·
4 min read
1 of 835
Next
